Penn Heart & Vascular interventionalist Howard Herrmann, MD, and cardiac surgeon Joseph Bavaria, MD, offer the insight of principal investigators as they discuss transcatheter aortic valve replacement (TAVR) therapy.
Exosomes as Biomarkers for Tissue Rejection in Transplant Recipients
Pericardial Disease: A New Look at an Old Disease
The Value of Social Media in Academic Medicine: What are the data?
Expanding Options with Transcatheter Aortic Valve Replacement
Transcatheter Aortic Valve Replacement (TAVR) Procedure
Treating VT like Cancer: Entirely Noninvasive Cardiac Mapping and Ablation – 2016 AHA Symposium, Part 6